Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdreView Imaging to Guide ICD Implantation in Heart Failure
NCT02656329Phase 3Terminated
- Sponsor
- GE HealthCare
- Start
- Dec 2015
- Primary completion
- May 2018
- Countries
- 10
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by GE HealthCare. Primary endpoint: All-cause Mortality at 304 days. Started Dec 2015; status: terminated.
Beyond the preview
Go deeper on NCT02656329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02656329.